Company Filing History:
1 out of 2 
1 out of 30 Years Active: 2025
Title: The Innovations of Janine Lossie: Pioneering Treatment for Neovascularization and Inflammation
Introduction
Janine Lossie is an esteemed inventor based in Berlin, Germany, known for her groundbreaking work in the field of biomedical innovations. Her contributions have focused on developing innovative treatments that target conditions associated with neovascularization and inflammation, particularly in ophthalmic disorders. With a steady commitment to research and development, Janine has secured a patent that highlights her profound impact in the medical field.
Latest Patents
Janine Lossie holds a significant patent titled "Analogs of CYP-eicosanoids for use in treating or preventing a disorder associated with neovascularization and/or inflammation." This invention pertains to the general formula (I) of compounds that are robust analogues of bioactive lipid mediators derived from omega-3 polyunsaturated fatty acids (n-3 PUFAs). The patented compounds are designed to treat or reduce the risk of developing inflammatory disorders and neovascularization, primarily targeting ophthalmic conditions characterized by such medical challenges.
Career Highlights
Throughout her professional journey, Janine Lossie has collaborated with prominent organizations such as Omeicos Therapeutics GmbH and Max-Delbrück-Centrum für Molekulare Medizin. These affiliations have allowed her to advance her research and contribute significantly to the development of therapeutic solutions in her field. Her exceptional work has established her as a respected figure among her peers and in the broader scientific community.
Collaborations
Janine has worked alongside distinguished colleagues, including Robert Fischer and Wolf-Hagen Schunck. Together, they have made considerable strides in understanding and developing treatments for disorders linked to inflammation and neovascularization. These collaborations have not only enhanced Janine's research capabilities but have also contributed to the overall advancement of medical science in this vital area.
Conclusion
Janine Lossie's dedication to innovation within the realm of biomedicine underscores the importance of developing new treatments for complex health issues. Her patent, focusing on the use of CYP-eicosanoids, illustrates her commitment to addressing critical healthcare challenges. As she continues her research and professional endeavors, Janine Lossie's contributions to the field will undoubtedly play a pivotal role in shaping future biomedical advancements.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.